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Background: There are a limited number of studies regarding the association between abdominal obesity and
serum adiponectin complexes (high, medium, and low molecular weight adiponectins) among population-based
elementary school children, especially in Japan, where blood collection is not usually performed during annual
health examinations of school children. The aim of the present study was to investigate the relationship between
abdominal obesity and serum adiponectin complexes among population-based elementary school children in
Japan.
Methods: Subjects were all the fourth-grade school children (9 or 10 years of age) in the town of Ina during
2005–2008 (N = 1675). The height, weight, percent body fat, and waist circumference (WC) of each subject were
measured. Blood samples were drawn from subjects to measure adiponectin isoform values. Childhood abdominal
obesity was defined as “a waist-to-height ratio greater than or equal to 0.5” or “a WC greater than or equal to
75 cm”. The Wilcoxon rank-sum test and the logistic regression model were used to analyze the association
between abdominal obesity and each adiponectin isoform value.
Results: Data from 1654 subjects (846 boys and 808 girls) were analyzed. Adiponectin complexes were lower in
the abdominal obesity group than in the non-abdominal obesity group regardless of sex. Abdominal obesity
significantly increased the odds ratio (OR) for each adiponectin isoform level less than or equal to the median
value in boys; the OR (95% confidence interval [CI]) was 2.50 (1.59-3.92) for high molecular weight adiponectin
(HMW-adn), 2.47 (1.57-3.88) for medium molecular weight adiponectin (MMW-adn), and 1.75 (1.13-2.70) for low
molecular weight adiponectin (LMW-adn). In girls, the OR (95% CI) was 1.95 (1.18-3.21) for HMW-adn, 1.40 (0.86-2.28)
for MMW-adn, and 1.06 (0.65-1.70) for LMW-adn.
Conclusions: Abdominal obesity was associated with lower adiponectin complexes and the influence of abdominal
obesity varied by adiponectin isoform. Furthermore, the impact of abdominal obesity was larger in boys than in
girls. The present study results suggest that prevention of abdominal obesity could contribute to the prevention of
lower adiponectin levels, especially in boys.
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Childhood obesity has important consequences on
health and well-being both during childhood and in later
adult life [1]. For example, cardiovascular risk factors
such as hypertension, dyslipidemia, and hyperinsuline-
mia/insulin resistance, which are known to be associated
with obesity in adults, are also associated with obesity in
children and adolescents [2]. Moreover, a recent study
demonstrated that overweight and obesity in childhood
and adolescence have adverse consequences on prema-
ture mortality in adulthood [3]. Therefore, childhood
obesity is a serious public health problem.
A previous study reported that obese individuals with
most of their fat stored in visceral adipose depots gener-
ally suffer greater adverse metabolic consequences than
those with fat stored predominantly in subcutaneous
sites [4]. Visceral adipose tissue (VAT) was shown to be
associated with many risk factors for chronic diseases
and was shown to be related to glucose metabolism,
lipid abnormalities, and hypertension [5]. In fact, epide-
miologic studies on the distribution of body fat have
shown that greater deposition of central fat is associated
with type 2 diabetes, less favorable plasma lipid and lipo-
protein concentrations, increased blood pressure, and in-
creased left ventricular mass [6,7]. These studies suggest
that the prevention of abdominal obesity (central obes-
ity) is very important.
Central obesity is reported to be associated with adipo-
nectin [8]. Adiponectin is a recently described adipokine
that has been recognized to be a key regulator of insulin
sensitivity and tissue inflammation [9]. It is specifically
and abundantly expressed in adipose tissue [10]. In hu-
man plasma, adiponectin circulates in distinct multi-
meric complexes forming trimeric low molecular weight
(LMW), hexameric medium molecular weight (MMW),
and oligomeric high molecular weight (HMW) comple-
xes [11]. Several studies have shown the relationship
between childhood obesity and adiponectin [12-14]. How-
ever, there are a limited number of studies regarding the
association between abdominal obesity and each adipo-
nectin isoform (HMW adiponectin [HMW-adn], MMW
adiponectin [MMW-adn], or LMW adiponectin [LMW-
adn]) among population-based elementary school chil-
dren, especially in Japan, where blood collection is not
usually performed during annual health examinations of
school children.
Accordingly, the aim of the present study was to inves-
tigate the relationship between abdominal obesity and
serum adiponectin complexes among population-based
elementary school children in Japan.
Methods
In addition to the annual national health checkups per-
formed in accordance with the School Health Law ofJapan, the town of Ina, located in Saitama Prefecture,
Japan, had conducted a unique health-promotion program
since 1994. In the program, blood and physical examina-
tions were performed for fourth and seventh graders. The
present study was conducted as part of this program.
Study subjects
Subjects comprised all the fourth-grade school children
(9 or 10 years of age) in Ina during 2005–2008. Written
informed consent was obtained from each subject’s par-
ent or guardian. This study protocol was approved by
the two independent institutional review boards at Showa
University School of Medicine and Jikei University School
of Medicine.
A total of 1,675 subjects were approached and 13 re-
fused to participate in the program (participation rate:
99.2%). Eight subjects were excluded because of incom-
plete data. Thus, data from 1,654 subjects (846 boys and
808 girls) were analyzed.
Anthropometric and biochemical measurements
The height and weight of each subject were measured in
the school’s infirmary or in a designated room to protect
the subject’s privacy during the procedures. For an-
thropometric measurements, subjects wore light cloth-
ing but no shoes or socks. Height was measured to the
nearest 0.1 cm using a stadiometer, and body weight was
measured to the nearest 0.1 kg using a scale. Body mass
index (BMI) was calculated as weight (kg) divided by
height (m) squared. Percent body fat was measured with
a bipedal biometrical impedance analysis device (Model
TBF-102, Tanita, Tokyo, Japan) to the nearest 0.1%, over
light clothing in a standing position. Waist circumfer-
ence (WC) was measured in a standing position at the
navel level while another examiner checked verticality
from the side. Waist-to-height ratio (WHtR) was calcu-
lated as WC divided by height.
Blood samples were drawn from subjects to measure
adiponectin isoform values. Adiponectin isoform values
were measured using a commercially available enzyme-
linked immunosorbent assay kit (Daiichi Pure Chemical
Co. Ltd., Tokyo, Japan) [15].
All measurements were recorded annually from 2005
to 2008.
Definition of abdominal obesity
Childhood abdominal obesity was defined as a WHtR ≥
0.5 or a WC ≥ 75 cm according to diagnostic criteria for
metabolic syndrome in Japanese children and adoles-
cents [16].
Data analysis
The Shapiro-Wilk test was used to test the normality of
distribution. To compare various characteristics between
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group vs. abdominal obesity group), the Wilcoxon rank-
sum test was used. Spearman’s correlation coefficients
were calculated between anthropometric variables and
each adiponectin isoform and among each adiponec-
tin isoform (HMW-adn vs. MMW-adn, HMW-adn vs.
LMW-adn, and MMW-adn vs. LMW-adn). The logistic
regression model was used to calculate the odds ratio
(OR) and 95% confidence intervals (95% CI) of abdom-
inal obesity for each adiponectin isoform (HMW-adn,
MMW-adn, or LMW-adn) ≤ the median value. The
index “adiponectin levels ≤ median value” was used in a
recent study and was shown to be associated with a sig-
nificantly increased risk of having metabolic syndrome
[17]. A P value < 0.05 was considered statistically sig-
nificant. All statistical analyses were performed using
Statistical Analysis System software (Version 9.2; SAS
Institute Inc., Cary, NC, USA).
Results
Characteristics were compared between boys and girls.
BMI, percent body fat, and WC were significantly higher in
boys (median: 16.6 kg/m2, 18.4%, and 57.5 cm, respectively)Table 1 Comparisons of characteristics between the non-abdo
(boys)
Non-abdominal obesity
Age (years) Median (IQR) 9.0(9.0–10.0
Mean±SD (95% CI) 9.3 ± 0.5(9.26–
Height (cm) Median (IQR) 134.5(130.5–13
Mean±SD (95% CI) 134.7 ± 5.7(134.3–
Weight (kg) Median (IQR) 29.6(26.8–32
Mean±SD (95% CI) 30.1 ± 4.6(29.8–
BMI (kg/m2) Median (IQR) 16.4(15.3–17
Mean±SD (95% CI) 16.5 ± 1.7(16.4–
PBF (%) Median (IQR) 17.9(15.3–21
Mean±SD (95% CI) 18.3 ± 4.2(18.0–
WC (cm) Median (IQR) 56.9(54.0–60
Mean±SD (95% CI) 57.4 ± 4.6(57.0–
WHtR Median (IQR) 0.42(0.40–0.4
Mean±SD (95% CI) 0.43 ± 0.03(0.42–
HMW-adn (μg/mL) Median (IQR) 2.73(1.91–4.0
Mean±SD (95% CI) 3.10 ± 1.67(2.98–
MMW-adn (μg/mL) Median (IQR) 1.82(1.48–2.1
Mean±SD (95% CI) 1.90 ± 0.63(1.86–
LMW-adn (μg/mL) Median (IQR) 1.64(1.34–2.0
Mean±SD (95% CI) 1.71 ± 0.52(1.67–
IQR interquartile range (25th percentile-75th percentile), SD standard deviation, CI c
circumference, WHtR waist-to-height ratio, HMW-adn high molecular weight adipon
weight adiponectin.
aWilcoxon rank-sum test.than in girls (16.3 kg/m2, 15.8%, and 57.3 cm, respectively).
HMW-adn and LMW-adn in girls (median: 2.83 μg/mL
and 1.68 μg/mL, respectively) were higher than values in
boys (2.65 μg/mL and 1.61 μg/mL, respectively).
Comparisons of characteristics between the non-
abdominal obesity group and the abdominal obesity
group among boys are shown in Table 1. All an-
thropometric variables in the abdominal obesity group
were significantly higher than in the non-abdominal
obesity group. Each adiponectin level was significantly
lower in the abdominal obesity group than in the
non-abdominal obesity group. WC and WHtR were sig-
nificantly negatively correlated with each adiponectin iso-
form value. HMW-adn was significantly correlated with
MMW-adn (r = 0.68, P < 0.001) and LMW-adn (0.44, P <
0.001), while MMW-adn was significantly correlated with
LMW-adn (0.33, P < 0.001).
Table 2 shows comparison of characteristics between
the non-abdominal obesity and the abdominal obesity
groups among girls. There were significant differences
between groups in all anthropometric variables. Each adi-
ponectin level was lower in the abdominal obesity group
than in the non-abdominal obesity group. WC and WHtRminal obesity group and the abdominal obesity group
group (n = 748) Abdominal obesity group (n=98) P valuea
) 9.0(9.0–10.0) 0.785
9.32) 9.3 ± 0.4(9.2–9.4)
8.7) 137.6(132.8–141.0) <0.001
135.1) 137.3 ± 6.4(136.0–138.6)
.8) 41.5(37.7–46.3) <0.001
30.5) 42.3 ± 7.5(40.8–43.8)
.6) 21.8(20.6–23.8) <0.001
16.6) 22.3 ± 2.7(21.8–22.8)
.1) 29.5(24.3–32.8) <0.001
18.6) 28.7 ± 5.6(27.6–29.8)
.1) 73.2(69.5–78.6) <0.001
57.7) 74.7 ± 7.1(73.3–76.2)
4) 0.53(0.51–0.57) <0.001
0.43) 0.54 ± 0.04(0.54–0.55)
0) 2.00(1.40–2.96) <0.001
3.22) 2.34 ± 1.45(2.05–2.63)
9) 1.60(1.36–1.86) <0.001
1.95) 1.63 ± 0.50(1.53–1.73)
3) 1.44(1.18–1.77) <0.001
1.74) 1.55 ± 0.63(1.42–1.67)
onfidence interval, BMI body mass index, PBF percent body fat, WC waist
ectin, MMW-adn medium molecular weight adiponectin, LMW low molecular
Table 2 Comparisons of characteristics between the non-abdominal obesity group and the abdominal obesity
group (girls)
Non-abdominal obesity group (n = 734) Abdominal obesity group (n=74) P valuea
Age (years) Median (IQR) 9.0(9.0–10.0) 9.0(9.0–10.0) 0.775
Mean±SD (95% CI) 9.3 ± 0.5(9.3–9.4) 9.3 ± 0.5(9.2–9.4)
Height (cm) Median (IQR) 134.1(130.0–138.8) 137.2(132.6–143.8) <0.001
Mean±SD (95% CI) 134.4 ± 6.2(133.9–134.8) 137.6 ± 7.5(135.9–139.4)
Weight (kg) Median (IQR) 28.8(26.0–32.3) 41.5(36.6–47.9) <0.001
Mean±SD (95% CI) 29.4 ± 4.7(29.1–29.8) 41.9 ± 7.7(40.1–43.7)
BMI (kg/m2) Median (IQR) 16.0(15.1–17.3) 21.4(20.7–23.0) <0.001
Mean±SD (95% CI) 16.2 ± 1.6(16.1–16.3) 21.9 ± 2.4(21.4–22.5)
PBF (%) Median (IQR) 15.4(13.2–18.4) 28.1(26.7–30.9) <0.001
Mean±SD (95% CI) 15.8 ± 3.8(15.5–16.0) 29.0 ± 4.8(27.9–30.2)
WC (cm) Median (IQR) 56.7(53.9–59.6) 72.1(69.5–77.8) <0.001
Mean±SD (95% CI) 57.0 ± 4.5(56.6–57.3) 73.4 ± 6.1(71.9–74.8)
WHtR Median (IQR) 0.42(0.40–0.44) 0.53(0.51–0.54) <0.001
Mean±SD (95% CI) 0.42 ± 0.03(0.42–0.43) 0.53 ± 0.03(0.53–0.54)
HMW-adn (μg/mL) Median (IQR) 2.90(1.89–3.98) 2.08(1.22–3.43) <0.001
Mean±SD (95% CI) 3.09 ± 1.59(2.97–3.20) 2.40 ± 1.48(2.05–2.74)
MMW-adn (μg/mL) Median (IQR) 1.78(1.45–2.19) 1.60(1.19–2.18) 0.025
Mean±SD (95% CI) 1.88 ± 0.61(1.83–1.92) 1.72 ± 0.67(1.57–1.88)
LMW-adn (μg/mL) Median (IQR) 1.69(1.35–2.07) 1.61(1.24–1.97) 0.195
Mean±SD (95% CI) 1.75 ± 0.58(1.71–1.79) 1.68 ± 0.59(1.55–1.82)
IQR interquartile range (25th percentile-75th percentile), SD standard deviation, CI confidence interval, BMI body mass index, PBF percent body fat, WC waist
circumference, WHtR waist-to-height ratio, HMW-adn high molecular weight adiponectin, MMW-adn medium molecular weight adiponectin, LMW low molecular
weight adiponectin.
aWilcoxon rank-sum test.
Table 3 Odds ratios and 95% confidence intervals of
abdominal obesity for each adiponectin level ≤ the








OR 95% CI P value
HMW-adiponectin
≤Median 356(47.6) 68(69.4) 2.50 1.59–3.92 <0.001
>Median 392(52.4) 30(30.6) 1.00
MMW-adiponectin
≤Median 358(47.9) 68(69.4) 2.47 1.57–3.88 <0.001
>Median 390(52.1) 30(30.6) 1.00
LMW-adiponectin
≤Median 363(48.5) 61(62.2) 1.75 1.13–2.70 0.011
>Median 385(51.5) 37(37.8) 1.00
HMW high molecular weight, MMW medium molecular weight, LMW low
molecular weight, OR odds ratio, CI confidence interval.
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nectin isoform. HMW-adn was significantly correlated
with MMW-adn (r = 0.61, P < 0.001) and LMW-adn (0.40,
P < 0.001), while MMW-adn was significantly correlated
with LMW-adn (0.27, P < 0.001).
ORs and 95% CIs of abdominal obesity for each adipo-
nectin isoform level ≤ the median value among boys are
shown in Table 3. Significantly increased ORs of abdo-
minal obesity were observed for HMW-adn (OR: 2.50,
95% CI: 1.59-3.92), MMW-adn (2.47, 1.57-3.88), and
LMW-adn (1.75, 1.13-2.70). Even when percent body fat
was adjusted for in the analysis, abdominal obesity signifi-
cantly increased the OR for each adiponectin isoform.
ORs and 95% CIs of abdominal obesity for each adipo-
nectin isoform level ≤ the median value among girls are
shown in Table 4. The OR of abdominal obesity was
1.95 (95% CI: 1.18-3.21) for HMW-adn, 1.40 (0.86-2.28)
for MMW-adn, and 1.06 (0.65-1.70) for LMW-adn.
When percent body fat was adjusted in the analysis, the
OR of abdominal obesity was not statistically significant
for each adiponectin isoform.
In the analysis among all subjects, the sex-adjusted OR
and 95% CI of abdominal obesity for each adiponectin
Table 4 Odds ratios and 95% confidence intervals of
abdominal obesity for each adiponectin level ≤ the








OR 95% CI P value
HMW-adiponectin
≤Median 357(48.6) 48(64.9) 1.95 1.18–3.21 0.009
>Median 377(51.4) 26(35.1) 1.00
MMW-adiponectin
≤Median 365(49.7) 43(58.1) 1.40 0.86–2.28 0.171
>Median 369(50.3) 31(41.9) 1.00
LMW-adiponectin
≤Median 367(50.0) 38(51.4) 1.06 0.65–1.70 0.825
>Median 367(50.0) 36(48.7) 1.00
HMW high molecular weight, MMW medium molecular weight, LMW low
molecular weight, OR odds ratio, CI confidence interval.
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(95% CI) was 2.28 (1.63-3.19) for HMW-adn, 1.94 (1.40-
2.70) for MMW-adn, and 1.51 (1.10-2.09) for LMW-adn.
Discussion
In the present study, the relationship between abdominal
obesity and serum adiponectin complexes was investi-
gated among population-based elementary school chil-
dren in Japan. Adiponectin complexes were lower in the
abdominal obesity group than in the non-abdominal
obesity group. Furthermore, the OR of abdominal obes-
ity for each adiponectin isoform level ≤ the median value
varied with each adiponectin isoform. These results sug-
gest that abdominal obesity was associated with lower
adiponectin complexes and that the influence of abdom-
inal obesity on each adiponectin isoform varied. To the
best of our knowledge, this is the first study on the asso-
ciation between abdominal obesity and adiponectin
complexes among population-based elementary school
children in Japan, where blood collection and measure-
ment of WC are not commonly performed in annual
health examinations at elementary schools. However, the
results of the present study should be discussed carefully.
Some baseline characteristics were significantly differ-
ent between boys and girls. For example, anthropometric
variables were higher in boys than in girls. Furthermore,
adiponectin levels were higher in girls than in boys. A
recent study reported that sex differences in body com-
position are present very early in life [18]. In addition,
serum adiponectin levels were reported to be higher in
girls than in boys [12,17]. Therefore, we analyzed the
data separately by sex and then examined the relationship
between abdominal obesity and adiponectin complexes.In this study, adiponectin complexes were lower in the
abdominal obesity group than in the non-abdominal
obesity group regardless of sex. A previous study showed
that adiponectin concentrations diminish as VAT in-
creases in children [14]. In fact, some studies reported
that serum adiponectin levels were lower in obese chil-
dren than in nonobese children [12,13], while levels were
reported to be lower in the high-VAT group than in the
low-VAT group among adolescents [19]. These results
were not inconsistent with our study results.
The OR of abdominal obesity for each adiponectin
isoform ≤ the median value varied among HMW-adn,
MMW-adn, and LMW-adn in the present study. These
results suggest that the impact of abdominal obesity
varied on each adiponectin isoform. A previous study
reported that the antidiabetogenic and antiatherogenic
properties of adiponectin are evident early in life and
compromised in youth-onset obesity [19]. Furthermore,
among three adiponectin isoforms (HMW-adn, MMW-
adn, and LMW-adn), HMW-adn has more biological
activity than either MMW-adn or LMW-adn [20,21].
Therefore, abdominal obesity in children leads to lower
adiponectin levels, especially HMW-adn levels, which
could increase the risk for diabetes and atheroscler-
osis in the future. In fact, a recent study showed that
decreased HMW-adn levels were associated with dia-
betes [22].
Sex differences regarding the influence of abdominal
obesity on adiponectin complexes were observed in the
present study; the OR for each adiponectin isoform ≤
the median value among boys was consistently higher
than that among girls. These results showed that the im-
pact of abdominal obesity on adiponectin complexes was
stronger in boys than in girls. A recent study showed the
relationship between obesity and testosterone [23], while
another study showed that serum testosterone levels
were associated with adiponectin concentrations among
children [24]. Furthermore, adiponectin levels were re-
ported to decline with age, in association with changes
in sex hormones and growth factors, and this relation-
ship appears to be more pronounced in boys than girls
[25]. Therefore, sex differences in the relationship be-
tween abdominal obesity and adiponectin levels could be
due to sex hormones. Because sex hormones were not
measured in the present study, further study will be
needed to elucidate sex differences.
The present study has some limitations. First, the
blood collection from study subjects was conducted in
the morning after eating breakfast, which might affect
the data. However, some studies have reported that the
level of circulating adiponectin does not change in re-
sponse to a high-fat meal or 75 g of oral glucose load
[26,27]. Accordingly, the present study results may not
be affected by postprandial status. The second limitation
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stage (Tanner’s stage), although it might be technically
difficult to obtain this information from more than 1,500
population-based children. A previous study showed that
the first sign of puberty was testicular growth (≥3 ml) in
Japanese boys, attained at a mean age of 10.8 years, and
breast development (Tanner stage 2) in girls at a mean
age of 10.0 years [28]. Because the mean age of our
study participants was 9.3 years, puberty stage was not
likely to have a substantial impact on study results.
Third, subjects in this study were from one town in
Japan. Therefore, it might be difficult to apply the present
study results to other populations. Finally, this study used
a cross-sectional design. Therefore, the possibility of re-
verse causality exists.Conclusions
The present study showed that abdominal obesity was
associated with lower adiponectin complexes, and the
influence of abdominal obesity varied with each adipo-
nectin isoform. Furthermore, the impact of abdominal
obesity was stronger in boys than in girls. These results
suggest that prevention of abdominal obesity could con-
tribute to the prevention of lower adiponectin levels, es-
pecially in boys.
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